PHBI's free cash flow for Q4 2023 was $-1.98K. For the 2023 fiscal year, PHBI's free cash flow was decreased by $352.73K and operating cash flow was $-1.98K. See a summary of the company’s cash flow.

Cash Flow	TTM	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Operating Cash Flow	$ -28.74K	$ -73.84K	$ -426.57K	$ -206.08K	$ -607.63K	$ -317.83K
Investing Cash Flow	-	-	-	-	$ 0.00	$ -196.13K
Financing Cash Flow	$ 36.53K	$ 83.37K	$ 313.71K	$ 257.50K	$ 562.62K	$ 432.83K
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 237.44K	$ 56.94K	$ 63.70K	$ 25.30K	$ 12.20K	$ 62.68K
Income Tax Paid Supplemental Data	-	-	-	-	$ 0.00	$ 0.00
Interest Paid Supplemental Data	-	-	-	-	$ 4.60K	$ 0.00
Issuance Of Capital Stock	-	-	$ 187.00K	$ 267.73K	$ 40.00K	$ 0.00
Issuance Of Debt	$ 36.53K	$ 83.37K	$ 126.71K	$ -10.24K	$ 696.16K	$ 322.47K
Repayment Of Debt	$ 2.57K	-	$ -14.85K	$ -87.77K	$ -168.54K	$ -59.35K
Free Cash Flow	$ -28.74K	$ -73.84K	$ -426.57K	$ -206.08K	$ -607.63K	$ -513.96K
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Pharmagreen Biotech Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing